Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence
Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted …

BACKGROUND Fear from increased cancer risk is one of the most significant reasons for
low acceptance of reliable contraceptive methods and low compliance. METHODS In this …

More than 15 case–control studies and at least four large cohort studies demonstrated a
decrease in the risk of endometrial cancer of about 50% for ever use of combined oral …

Endometrial cancer (EC) is the most common gynaecological malignancy, and its incidence
is rising alongside the growing prevalence of obesity. Effective risk-reducing interventions …

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been
shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as …

This ninety-first volume of IARC Monographscontains evaluations of the carcinogenic
hazard to humans of combined estrogen-progestogen contraceptives and combined …

PURPOSE: We sought to study the association between intrauterine device (IUD) use and
endometrial cancer. METHODS: A comprehensive search of literature published through …

Intrauterine devices (IUDs), long‐acting and reversible contraceptives, induce a number of
immunological and biochemical changes in the uterine environment that could affect …

BACKGROUND. Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)
have an increased lifetime risk for endometrial and ovarian cancer. Screening and …

BACKGROUND: One of the mechanisms by which intrauterine devices (IUDs) prevent
pregnancy is the creation of a sterile inflammatory response in the endometrium …